Elucid is a non-invasive cardiac imaging company that competes with HeartFlow, but goes beyond by quantifying plaque based on histopathology. It’s an FDA-cleared tool that helps avoid invasive cath lab procedures and helps physician identify patients who need more aggressive treatments.
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.